Extending the Construct Network of Trait Disinhibition to the Neuroimaging Domain: Validation of a Bridging Scale for Use in the European IMAGEN Project

Standard

Extending the Construct Network of Trait Disinhibition to the Neuroimaging Domain: Validation of a Bridging Scale for Use in the European IMAGEN Project. / Brislin, Sarah J; Patrick, Christopher J; Flor, Herta; Nees, Frauke; Heinrich, Angela; Drislane, Laura E; Yancey, James R; Banaschewski, Tobias; Bokde, Arun L W; Bromberg, Uli; Büchel, Christian; Quinlan, Erin Burke; Desrivières, Sylvane; Frouin, Vincent; Garavan, Hugh; Gowland, Penny; Heinz, Andreas; Ittermann, Bernd; Martinot, Jean-Luc; Martinot, Marie-Laure Paillère; Papadopoulos Orfanos, Dimitri; Poustka, Luise; Fröhner, Juliane H; Smolka, Michael N; Walter, Henrik; Whelan, Robert; Conrod, Patricia; Stringaris, Argyris; Struve, Maren; van Noort, Betteke; Grimmer, Yvonne; Fadai, Tahmine; Schumann, Gunter; Foell, Jens.

In: ASSESSMENT, Vol. 26, No. 4, 06.2019, p. 567-581.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Brislin, SJ, Patrick, CJ, Flor, H, Nees, F, Heinrich, A, Drislane, LE, Yancey, JR, Banaschewski, T, Bokde, ALW, Bromberg, U, Büchel, C, Quinlan, EB, Desrivières, S, Frouin, V, Garavan, H, Gowland, P, Heinz, A, Ittermann, B, Martinot, J-L, Martinot, M-LP, Papadopoulos Orfanos, D, Poustka, L, Fröhner, JH, Smolka, MN, Walter, H, Whelan, R, Conrod, P, Stringaris, A, Struve, M, van Noort, B, Grimmer, Y, Fadai, T, Schumann, G & Foell, J 2019, 'Extending the Construct Network of Trait Disinhibition to the Neuroimaging Domain: Validation of a Bridging Scale for Use in the European IMAGEN Project', ASSESSMENT, vol. 26, no. 4, pp. 567-581. https://doi.org/10.1177/1073191118759748

APA

Brislin, S. J., Patrick, C. J., Flor, H., Nees, F., Heinrich, A., Drislane, L. E., Yancey, J. R., Banaschewski, T., Bokde, A. L. W., Bromberg, U., Büchel, C., Quinlan, E. B., Desrivières, S., Frouin, V., Garavan, H., Gowland, P., Heinz, A., Ittermann, B., Martinot, J-L., ... Foell, J. (2019). Extending the Construct Network of Trait Disinhibition to the Neuroimaging Domain: Validation of a Bridging Scale for Use in the European IMAGEN Project. ASSESSMENT, 26(4), 567-581. https://doi.org/10.1177/1073191118759748

Vancouver

Bibtex

@article{492ec58a60714b0490689bf2179cc077,
title = "Extending the Construct Network of Trait Disinhibition to the Neuroimaging Domain: Validation of a Bridging Scale for Use in the European IMAGEN Project",
abstract = "Trait disinhibition, a clinical-liability construct, has well-established correlates in the diagnostic, self-rating, task-behavioral, and brain potential response domains. Recently, studies have begun to test for neuroimaging correlates of this liability factor, but more work of this type using larger data sets is needed to clarify its brain bases. The current study details the development and validation of a scale measure of trait disinhibition composed of questionnaire items available in the IMAGEN project, a large-scale longitudinal study of factors contributing to substance abuse that includes clinical interview, self-report personality, task-behavioral, neuroimaging, and genomic measures. Using a construct-rating and psychometric refinement approach, a scale was developed that evidenced: (a) positive relations with interview-assessed psychopathology in the IMAGEN sample, both concurrently and prospectively and (b) positive associations with scale measures of disinhibition and reported psychopathology, and a robust negative correlation with P3 brain response, in a separate adult sample ( Mage = 19.5). These findings demonstrate that a common scale measure can index this construct from adolescence through to early adulthood, and set the stage for systematic work directed at identifying neural and genetic biomarkers of this key liability construct using existing and future data from the IMAGEN project.",
author = "Brislin, {Sarah J} and Patrick, {Christopher J} and Herta Flor and Frauke Nees and Angela Heinrich and Drislane, {Laura E} and Yancey, {James R} and Tobias Banaschewski and Bokde, {Arun L W} and Uli Bromberg and Christian B{\"u}chel and Quinlan, {Erin Burke} and Sylvane Desrivi{\`e}res and Vincent Frouin and Hugh Garavan and Penny Gowland and Andreas Heinz and Bernd Ittermann and Jean-Luc Martinot and Martinot, {Marie-Laure Paill{\`e}re} and {Papadopoulos Orfanos}, Dimitri and Luise Poustka and Fr{\"o}hner, {Juliane H} and Smolka, {Michael N} and Henrik Walter and Robert Whelan and Patricia Conrod and Argyris Stringaris and Maren Struve and {van Noort}, Betteke and Yvonne Grimmer and Tahmine Fadai and Gunter Schumann and Jens Foell",
year = "2019",
month = jun,
doi = "10.1177/1073191118759748",
language = "English",
volume = "26",
pages = "567--581",
journal = "ASSESSMENT",
issn = "1073-1911",
publisher = "SAGE Publications",
number = "4",

}

RIS

TY - JOUR

T1 - Extending the Construct Network of Trait Disinhibition to the Neuroimaging Domain: Validation of a Bridging Scale for Use in the European IMAGEN Project

AU - Brislin, Sarah J

AU - Patrick, Christopher J

AU - Flor, Herta

AU - Nees, Frauke

AU - Heinrich, Angela

AU - Drislane, Laura E

AU - Yancey, James R

AU - Banaschewski, Tobias

AU - Bokde, Arun L W

AU - Bromberg, Uli

AU - Büchel, Christian

AU - Quinlan, Erin Burke

AU - Desrivières, Sylvane

AU - Frouin, Vincent

AU - Garavan, Hugh

AU - Gowland, Penny

AU - Heinz, Andreas

AU - Ittermann, Bernd

AU - Martinot, Jean-Luc

AU - Martinot, Marie-Laure Paillère

AU - Papadopoulos Orfanos, Dimitri

AU - Poustka, Luise

AU - Fröhner, Juliane H

AU - Smolka, Michael N

AU - Walter, Henrik

AU - Whelan, Robert

AU - Conrod, Patricia

AU - Stringaris, Argyris

AU - Struve, Maren

AU - van Noort, Betteke

AU - Grimmer, Yvonne

AU - Fadai, Tahmine

AU - Schumann, Gunter

AU - Foell, Jens

PY - 2019/6

Y1 - 2019/6

N2 - Trait disinhibition, a clinical-liability construct, has well-established correlates in the diagnostic, self-rating, task-behavioral, and brain potential response domains. Recently, studies have begun to test for neuroimaging correlates of this liability factor, but more work of this type using larger data sets is needed to clarify its brain bases. The current study details the development and validation of a scale measure of trait disinhibition composed of questionnaire items available in the IMAGEN project, a large-scale longitudinal study of factors contributing to substance abuse that includes clinical interview, self-report personality, task-behavioral, neuroimaging, and genomic measures. Using a construct-rating and psychometric refinement approach, a scale was developed that evidenced: (a) positive relations with interview-assessed psychopathology in the IMAGEN sample, both concurrently and prospectively and (b) positive associations with scale measures of disinhibition and reported psychopathology, and a robust negative correlation with P3 brain response, in a separate adult sample ( Mage = 19.5). These findings demonstrate that a common scale measure can index this construct from adolescence through to early adulthood, and set the stage for systematic work directed at identifying neural and genetic biomarkers of this key liability construct using existing and future data from the IMAGEN project.

AB - Trait disinhibition, a clinical-liability construct, has well-established correlates in the diagnostic, self-rating, task-behavioral, and brain potential response domains. Recently, studies have begun to test for neuroimaging correlates of this liability factor, but more work of this type using larger data sets is needed to clarify its brain bases. The current study details the development and validation of a scale measure of trait disinhibition composed of questionnaire items available in the IMAGEN project, a large-scale longitudinal study of factors contributing to substance abuse that includes clinical interview, self-report personality, task-behavioral, neuroimaging, and genomic measures. Using a construct-rating and psychometric refinement approach, a scale was developed that evidenced: (a) positive relations with interview-assessed psychopathology in the IMAGEN sample, both concurrently and prospectively and (b) positive associations with scale measures of disinhibition and reported psychopathology, and a robust negative correlation with P3 brain response, in a separate adult sample ( Mage = 19.5). These findings demonstrate that a common scale measure can index this construct from adolescence through to early adulthood, and set the stage for systematic work directed at identifying neural and genetic biomarkers of this key liability construct using existing and future data from the IMAGEN project.

U2 - 10.1177/1073191118759748

DO - 10.1177/1073191118759748

M3 - SCORING: Journal article

C2 - 29557190

VL - 26

SP - 567

EP - 581

JO - ASSESSMENT

JF - ASSESSMENT

SN - 1073-1911

IS - 4

ER -